There is ample experimental and clinical evidence of functional and structural microvascular abnormalities occurring in patients with Chagas cardiomyopathy, possibly due to the infl ammatory process and/or autonomic disturbances caused by Trypanosoma cruzi infection. Those microvascular derangements are likely to constitute at least an ancillary factor that potentiates and amplifi es the chronic infl ammation in myocardial tissue. It is possible to devise appropriate therapeutic interventions aimed at reverting or slowing the progression of the microvascular abnormalities to positively affect the natural history of Chagas cardiomyopathy.
INTRODUCTION
One hundred years after the discovery of Chagas disease, the pathogenesis of chronic Chagas cardiomyopathy (CCC) is still open to debate 1 . Nevertheless, there is both experimental and clinical evidence of coronary microvascular disturbances leading to ischemic myocardial damage in animals infected with Trypanosoma cruzi and in patients with chronic Chagas heart disease 2 .
EVIDENCE FROM HISTOPATHOLOGY STUDIES IN HUMANS
Necroscopic studies of patients who died in the acute phase of Chagas disease showed perivascular infl ammatory changes that were considered to be involved in causing myocardial damage 3 . Further necropsy studies of chronic Chagas patients also described extensive vascular lesions, with obstruction of the small intramural coronary artery branches due to intimal proliferation and arteriole wall thickening. In addition, the myocardial fi bers topographically related to these vascular lesions presented myocytolytic necrosis, a type of cell death related to ischemic injury 4 . The authors concluded that microvascular ischemia is directly involved in the genesis of the fundamental histopathologic pattern of CCC, consisting of diffuse focal myocarditis associated with myocytolysis and subsequent reparative fi brosis 5 . Another type of structural derangement is related to the rarefaction of the microvessels into the myocardium. This process of decapillarization was thought to be related to extraluminal compression and was shown to be topographically related to foci of myocytolysis, as demonstrated by a necroscopic radiological study of Chagas disease patients using a coronary injection of an opaque medium 6 . Vascular changes characterized by a decreased density of coronary vessels were confi rmed in another postmortem radiological study of patients with proven Chagas disease 7 .
Microvascular abnormalities due to the extensive basement membrane thickening of capillaries were also thought to be associated with the focal diffuse myocytolysis observed in both necroscopic studies and biopsy specimens 8 . Other independent investigations confi rmed the occurrence of structural changes in the microvascular coronary tree, with both abnormal dilation and constriction leading to myocardial damage in patients with Chagas disease [9] [10] [11] [12] . In addition, considering that the focal distribution of cell necrosis and subsequent reparative interstitial fi brosis observed in Chagas disease follows a pattern similar to that described in experimental models of ischemia and reperfusion, transient microvascular ischemic disturbances of low intensity and short duration have been postulated to cause ischemic myocardial damage and to ultimately lead to the development of cardiomyopathy 13, 14 . Coalescent microinfarctions have also been implicated in the genesis of the typical Chagas disease-related ventricular aneurysms that are postulated to occur in watershed coronary areas 15 . Further necropsy studies in humans correlated the presence of an apical aneurysm with scores proportional to the myocardial mass and coronary perfusion and concluded that ischemic factors could be involved in the genesis of the peculiar lesion of Chagas cardiomyopathy 16 . Following the demonstration that isoproterenol infusion in experimental animals without T. cruzi infection led to the formation of ventricular aneurysms similar to those found in Chagas disease, the neurogenic theory of chronic Chagas disease posited an abnormality in the autonomic control of the coronary circulation that would lead to overactivity of the sympathetic system, causing chronic myocardial ischemia 17 . These investigators also performed a macroscopic study in necropsied patients with Chagas disease and described an increased capacity of the coronary artery bed. The authors concluded that these fi ndings would lend further support to the neurogenic pathogenesis concept 18 . However, this issue is controversial because an in vivo study using quantitative coronary angiography in Chagas heart disease patients with chest pain and no obstructive coronary artery disease (CAD) in the subepicardial vessels showed that the baseline coronary artery diameter and tonus were not related to the degree of autonomic dysfunction 19 .
EVIDENCE FROM ANIMAL MODELS OF T. CRUZI INFECTION AND IN VITRO STUDIES
Early studies in the 1970s used histopathologic and histoenzymologic methods to compare the myocardial lesions found in Wistar rats chronically infected with T. cruzi with those lesions detected in other rats submitted to repeated injections of isoproterenol. The researchers found that there was marked histoenzymatic similarity between the lesions found in both experimental models and concluded that the myocardial damage described in the rats with T. cruzi infection could be caused by ischemia triggered by excessive stimulation with catecholamines 20 . Using histochemical methods in mice chronically infected with T. cruzi, several independent investigators have described microcirculatory derangements that cause ischemia associated with occlusive platelet thrombi in small epicardial and intramural coronary arteries 21, 22 . In the same experimental model, other microvascular derangements were detected, such as focal areas of vascular constriction and endothelial microvascular proliferation 23 . Similar alterations have been found in other models of experimental T. cruzi infection, including the development of typical ventricular aneurysms 24 . The mechanisms responsible for occlusive platelet thrombosis and microcirculatory spasm were directly related to the T. cruzi infection causing endothelial cell damage 25 and indirectly related to the interaction of the endothelium with immune effector cells 26, 27 . In vitro studies of T. cruzi infection of human umbilical vein endothelium cells showed increased production of endothelin. This potent vasoconstrictor mediated arteriolar spasm and impaired cyclic adenosine monophosphate (AMP) metabolism, thus impairing AMP's protective role against platelet adhesion to and aggregation along the vascular wall 28, 29 . Trypomastigote forms of T. cruzi also produce a neuraminidase that may remove sialic acid from the surface of mammalian myocardial and endothelial cells 30 . The loss of this protective component of the endothelial surface may be associated with platelet aggregation and microvascular thrombosis. These abnormal findings were corroborated by increased production of thromboxane-A2 and enhanced platelet adherence and aggregation in an experimental murine model of T. cruzi infection 31 . The increased production of cytokines by infl ammatory cells is also likely to contribute to microvascular abnormal reactivity in experimental models of Chagas heart disease 32 . These abnormalities have been shown to be reverted by verapamil, a vasodilatory calcium channel blocker with antiplatelet properties, thus attenuating myocardial aggression and, more importantly, leading to increased survival of mice acutely infected with T. cruzi 33 . These fi ndings were also corroborated by direct in vivo visualization of the murine cremaster vascular bed. This model showed that animals infected with T. cruzi had arterioles with segmental areas of spasm and reduced flow velocity; these abnormalities, which were not observed in control mice, were also antagonized by treatment with verapamil 34 . Finally, disturbed molecular mechanisms are thought to modify the function of the microcirculation in Chagas cardiomyopathy. For example, calreticulin, a calcium-binding protein that is also present in the parasite, was shown to interfere with modulation of the complement system and inhibit angiogenesis 35 .
EVIDENCE FROM CLINICAL STUDIES
Myocardial ischemic manifestations are commonly detected in patients with Chagas heart disease and may contribute to the pathogenesis of the disease's complex pathophysiology. Atypical angina pectoris is a common complaint in T. cruziinfected patients 36 . The characteristics of the chest pain are slightly consistent with ischemic cardiac pain (location and character) but typically have no relation to effort and no relief by the use of nitrates. Most of these patients have concomitant transient or defi nite ST-T changes on a 12-lead electrocardiogram (ECG) and abnormal Q waves compatible with electrically inactive left ventricular (LV) areas 37 ,38 . More rarely, patients may present with a clinical picture that mimics an acute coronary syndrome 37 . Similar to coronary heart disease, segmental LV wall motion abnormalities are common in patients with chronic Chagas disease and are even occasionally detected when the LV chamber is already globally dilated 39, 40 . Despite the occurrence of all of these manifestations, suggesting the presence of myocardial ischemia, catheter-based coronary angiography in Chagas' cardiomyopathy nearly invariably demonstrates the absence of signifi cant obstructive coronary disease at the epicardial level [36] [37] [38] [39] [40] [41] .
CORONARY MACROVASCULAR DYSFUNCTION
Although the angiographic appearance of the coronary arteries is normal in most patients with chest pain and documented T. cruzi infection, impairment of the regulation of the coronary circulation may occur at the macrovascular level. The possibility of coronary spasm was postulated as causing acute myocardial infarction in Chagas disease patients with normal coronary arteries 42 . However, other investigators showed no evidence of coronary artery spasm in any of 31 consecutive patients with Chagas' disease who exhibited precordial pain severe enough to warrant cardiac catheterization, despite the specifi c stimulus of the forced hyperventilation test Consistent with the experimental studies discussed above, impairment of endothelium-dependent coronary vasodilatation in response to acetylcholine has been reported in patients with Chagas' heart disease, but these patients had a preserved response to the non-endothelium-dependent effect of adenosine 43 . In another study, Chagas patients with angina that was atypical but severe enough to warrant coronary angiography had blunted vasomotor epicardial responses to hyperventilation and isosorbide dinitrate 44 . These combined fi ndings suggest that abnormal coronary fl ow regulation may be caused by endothelial and non-endothelial dysfunction in Chagas patients with chest pain and angiographically normal epicardial coronary arteries. However, there are no conclusive data showing that these functional macrovascular derangements have any relevant impact on the pathogenesis of Chagas cardiomyopathy.
CORONARY MICROVASCULAR DYSFUNCTION
Since the 1970s, the pioneering work of Emilio Kuschnir and his collaborators in Córdoba, Argentina, employing primitive nuclear medicine methods (the measurement of global myocardial fl ow with 86-rubidium), showed that chronic Chagas patients, similar to patients with CAD, exhibited a reduction in myocardial perfusion at rest and during physical exercise in comparison with normal individuals [45] [46] [47] . Several other investigations have subsequently described striking myocardial perfusion abnormalities in Chagas disease patients with angiographically normal coronary arteries, thus supporting the concept of abnormal fl ow regulation that essentially occurs at the microvascular level 41,48,4 9 . Using 201-thallium stress-redistribution myocardial perfusion scintigraphy (MPS), one of these investigations demonstrated at least one perfusion defect in all 23 chagasic patients studied 48 .
Fixed defects, connoting myocardial fi brosis, were found in myocardial segments exhibiting akinesis or dyskinesis, and stress-induced, reversible myocardial ischemia was detected in LV segments with less severe wall motion impairment in 8 (35%) patients 48 . These fi ndings were confi rmed and extended by a further study of 37 patients with various stages of Chagas heart disease 49 . Regional MPS was also assessed by the use of 201-thallium with single-photon emission computed tomography (SPECT), this time focusing on the topographic correlation between segmental myocardial perfusion abnormalities and regional LV dysfunction. Perfusion defects (fi xed, paradoxical and reversible) were observed in most (78%) of the patients, and a signifi cant topographic correlation was observed between perfusion disturbances and wall motion abnormalities predominating in the apical and inferior-posterior LV segments. Reversible, stressinduced myocardial perfusion defects were detected in segments exhibiting normal wall motion in 5 (42%) of 12 Chagas disease patients who otherwise had no evidence of myocardial disease (possibly with the indeterminate form of the disease) 49 . Of note, these reversible ischemic defects were mostly observed in the apical and inferior-posterior LV segments, i.e., the same regions in which regional contractile dysfunction is more frequently found in later stages of Chagas cardiomyopathy 49 . An additional intriguing fi nding was that marked sympathetic denervation, as evaluated by myocardial scintigraphy with iodine-123-metaiodobenzylguanidine (MIBG), was demonstrated in topographic association with the presence of perfusion abnormalities in patients with less advanced deterioration of LV function 49 .
This fi nding suggests that the sympathetic denervation and perfusion derangements may be pathophysiologically linked and that these events occur at early stages in the natural course of Chagas cardiomyopathy, before the installation of typical segmental contractile dysfunction. This suggestion may indeed be the case based on a more recent study of 36 patients with serologically proven Chagas disease who were initially evaluated with Tc-99m-Sestamibi MPS at rest and during physical exercise and who had the nuclear examination repeated after a mean period of 5.6 years 50 . Of the 36 patients, 20 (56%) exhibited reversible ischemic myocardial perfusion defects involving an average of 10.2% ± 9.7% of the LV area, as determined by the SPECT technique. A topographic association between the presence of ischemia in the initial evaluation and the development of myocardial fi brosis was suggested by the results, as among the 47 segments presenting reversible perfusion defects in the initial study, 32 (68%) progressed to perfusion defects at rest, and of the 469 segments not showing reversibility in the initial study, only 41 (8.7%) had the same progression. The individual increase in the perfusion defect area at rest (possibly indicating the presence of fi brosis) was signifi cantly correlated with the corresponding reduction in LV ejection fraction (with a mean decrease over time in the entire group of patients from 55% ± 11% to 50% ± 13%). Hence, in this longitudinal study, the deterioration of LV systolic function over time was associated with both the presence of reversible ischemic defects at the initial assessment and an increase in the extent of irreversible perfusion defects during follow-up 50 .
In patients with Chagas cardiomyopathy selected for malignant ventricular arrhythmia, perfusion defects were also predominant in areas from which the reentrant circuits frequently arise 51 .
Although the mentioned studies have shown that the detection of microvascular myocardial ischemia is associated with a worse outcome regarding ventricular function, the role of MPS in the detection of early myocardial involvement in patients with the indeterminate form of chronic Chagas disease is more unclear. A recent study found normal myocardial perfusion in all 18 patients with the indeterminate form of Chagas disease who were submitted to stress-rest MPS with Tc-99m-Sestamibi 52 .
Because the tracer used in most previously mentioned studies 41, 48, 49 was 201-thallium (Figure 1 depicts an illustrative example), its accumulation and retention could be infl uenced by cardiomyocyte metabolic derangements related to the underlying infl ammatory process. Hence, the scintigraphic defects described in the previous studies might not represent true perfusion abnormalities. This alternative possibility is supported by the frequent occurrence of reverse redistribution defects predominating in LV regions with normal or mildly impaired wall motion in those studies. However, myocardial perfusion was also evaluated in 18 chronic Chagas' heart disease patients with recurrent chest pain that was severe enough to warrant coronary angiography using an exclusive perfusion tracer, 99m-technetium-labeled microspheres, injected into the LV cavity 44 . All patients presented normal epicardial coronary arteries. Ten of the 18 patients exhibited extensive perfusion defects in 49 (39%) of 126 LV segments. In total, 19 (40%) of these segments with perfusion defects had severely impaired wall motion, most likely corresponding to extensive fi brosis. The remaining 60% of the segments with perfusion defects had normal or mildly reduced wall motion. Thus, this investigation clearly showed marked resting myocardial perfusion abnormalities preceding the appearance of any wall motion impairment 44 More recently, the use of magnetic resonance imaging (MRI) to examine patients with CCC has been reported 53, 54 . In one study, 51 patients with CCC were investigated by MRI, including techniques of late contrast enhancement, for the detection of myocardial fi brosis. Myocardial fi brosis was found in 20% of 15 patients with the indeterminate form and in 84.6% of 26 patients with overt Chagas heart disease. The distribution of fi brosis was atypical for CAD and predominated in the midwall and subepicardial portions of the LV walls, encompassing multiple coronary territories. This pattern was compatible with myocardial fi brosis associated with myocardial ischemia secondary to microvascular derangement and chronic myocarditis, as also documented in hypertrophic and dilated cardiomyopathy 55, 56 . Similar fi ndings and interpretation were reported by another study, which investigated 67 Chagas disease patients. Late enhancement was detected in 23.9% of the patients, with a highly heterogeneous distribution: subendocardial in 26.8%, midwall in 14%, subepicardial in 22.6% and transmural in 36% 54 .
PATHOPHYSIOLOGICAL CONSEQUENCES OF CORONARY MICROVASCULAR PERFUSION DISTURBANCES AND THERAPEUTIC PERSPECTIVES ON CHAGAS DISEASE
On the basis of these clinical investigations and the background information from the pathological and experimental studies discussed, it is reasonable to hypothesize that myocardial perfusion derangements could contribute to the development of the characteristic segmental LV dysfunction observed in the chronic phase of Chagas heart disease. This pathophysiological mechanism may be similar to the chronic hyperperfusion that causes hibernating myocardium in patients with longstanding coronary artery disease. A corollary is that at least in the early stages of the disease, wall motion abnormalities due to ischemia may be reversible in Chagas patients. This concept is compatible with evidence from studies showing improvement in LV function in Chagas heart disease patients who received acute or chronic administration of dipyridamole 57 and isosorbide dinitrate 58 . However, these studies obtained no direct evidence indicating that the improvement in LV function was due to the relief of myocardial ischemia. In fact, the associated changes in ventricular loading conditions caused by the administration of dipyridamole and nitrate might have contributed to the improvement in ventricular performance. Only one study directly addressed the question of hibernating myocardium in CCC. The study was performed using post-extrasystolic potentiation, which is commonly observed during radiologicalcontrast left ventriculography, and showed that most myocardial areas with impaired wall motion indeed had a contractile reserve; that is, these areas were viable 59 . However, the hypothesis that hypokinetic areas of viable myocardium, unmasked through post-extrasystolic potentiation, would be predominant in regions exhibiting scintigraphic, reversible (ischemic) perfusion defects, was not confi rmed by the results of the study 60 .
Thus, although scientifi cally attractive, the hypothesis of chronic myocardial ischemia in Chagas' cardiomyopathy awaits a direct demonstration of benefi t to be derived from the long-term administration of drugs acting upon the microcirculation, with a signifi cant impact on the outcome of Chagas disease patients with angina-like symptoms. One such study is currently ongoing, with the primary objective of testing the hypothesis that the prolonged administration of verapamil and acetylsalicylic acid to Chagas patients with normal epicardial coronary arteries, chest pain and reversible ischemic perfusion defects at baseline examination will lead to a reduction in the extent and intensity of the perfusion abnormalities and a mitigation of the angina-like symptoms 61 . Finally, as the pathological changes found in the microvasculature of patients with chronic Chagas disease are linked either directly or indirectly to the persistence of T. cruzi, it is reasonable to speculate that therapy aimed at eliminating the parasite could prevent or ameliorate the microcirculatory disturbances. This hypothesis is reasonable, despite recent guidelines being evasive in recommending trypanocidal treatment for patients in the chronic phase of Chagas disease 
